WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004026872) PYRAZOLOPYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/026872    International Application No.:    PCT/US2003/029841
Publication Date: 01.04.2004 International Filing Date: 17.09.2003
Chapter 2 Demand Filed:    22.03.2004    
IPC:
C07D 471/04 (2006.01)
Applicants: SCHERING CORPORATION [US/US]; 2000 Galloping Hill Road, Kenilworth, NJ 07033-0530 (US)
Inventors: DWYER, Michael, P.; (US).
GUZI, Timothy, J.; (US).
PARUCH, Kamil; (US).
DOLL, Ronald, J.; (US).
KEERTIKAR, Kartik, M.; (US).
GIRIJAVALLABHAN, Viyyoor, M.; (US)
Priority Data:
60/412,138 19.09.2002 US
Title (EN) PYRAZOLOPYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
(FR) PYRAZOLOPYRIDINES UTILISEES COMME INHIBITEURS DE LA KINASE DEPENDANTE DES CYCLINES
Abstract: front page image
(EN)In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyridine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
(FR)Dans ses nombreux modes de réalisation, la présente invention concerne une nouvelle classe de composés de pyrazolo[1,5-a]pyridine utilisés comme inhibiteurs de kinases dépendantes des cyclines, les procédés de préparation de ces composés, des compositions pharmaceutiques contenant au moins un tel composé, des procédés de préparation de formulations pharmaceutiques contenant au moins un tel composé, et des procédés de traitement, de prévention, d'inhibition, ou d'amélioration d'au moins une maladie liée aux kinases dépendantes des cyclines à l'aide de ces composés ou compositions pharmaceutiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, HR, HU, ID, IL, IN, IS, JP, KG, KR, KZ, LC, LK, LR, LT, LU, LV, MA, MD, MG, MK, MN, MX, MZ, NI, NO, NZ, PG, PH, PL, PT, RO, RU, SC, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UZ, VC, VN, YU, ZA, ZM.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)